[1] SCOTT R M,SMITH E R. Moyamoya disease andmoyamoya syndrome[J]. N Engl J Med,2009,360(12):1226-1237.[2] KIM J S. Moyamoya disease:epidemiology,clinicalfeatures,and diagnosis[J]. J Stroke,2016,18(1):2-11.[3] LEE M,ZAHARCHUK G,GUZMAN R,et al.Quantitative hemodynamic studies in moyamoyadisease:a review[J/OL]. Neurosurg Focus,2009,26(4):E5[2019-12-26]. https://doi.org/10.3171/2009.1.FOCUS08300.[4] NOGUCHI T,KAWASHIMA M,IRIE H,et al.Arterial spin-labeling MR imaging in moyamoyadisease compared with SPECT imaging[J/OL]. Eur JRadiol,2011,80(3):e557-e562[2019-12-26]. https://doi.org/10.1016/j.ejrad.2011.01.016.[5] KAMANO H,YOSHIURA T,HIWATASHI A,etal. Arterial spin labeling in patients with chroniccerebral artery steno-occlusive disease:correlationwith(15)O-PET[J]. Acta Radiol,2013,54(1):99-106.[6] QIAO P G,HAN C,ZUO Z W,et al. Clinicalassessment of cerebral hemodynamics in Moyamoyadisease via multiple inversion time arterial spinlabeling and dynamic susceptibility contrastmagneticresonance imaging:a comparative study[J].J Neuroradiol,2017,44(4):273-280.[7] Research Committee on the Pathology and Treatmentof Spontaneous Occlusion of the Circle of Willis,Health Labour Sciences Research Grant for Researchon Measures for Infractable Diseases. Guidelinesfor diagnosis and treatment of moyamoya disease(spontaneous occlusion of the circle of Willis)[J].Neurol Med Chir(Tokyo),2012,52(5):245-266.[8] ZAHARCHUK G,DO H M,MARKS M P,et al.Arterial spin-labeling MRI can identify the presenceand intensity of collateral perfusion in patients withmoyamoya disease[J]. Stroke,2011,42(9):2485-2491.[9] MUTSAERTS H J,PETR J,VÁCLAV? L,et al.The spatial coefficient of variation in arterial spinlabeling cerebral blood flow images[J]. J CerebBlood Flow Metab,2017,37(9):3184-3192.[10] WOLF R L,DETRE J A. Clinical neuroimagingusing arterial spin-labeled perfusion magneticresonance imaging[J]. Neurotherapeutics,2007,4 (3):346-359.[11] NAEL K,MESHKSAR A,LIEBESKIND D S,etal. Periprocedural arterial spin labeling and dynamicsusceptibility contrast perfusion in detection ofcerebral blood flow in patients with acute ischemicsyndrome[J]. Stroke,2013,44(3):664-670.[12] GOETTI R,O'GORMAN R,KHAN N,et al.Arterial spin labelling MRI for assessment ofcerebral perfusion in children with moyamoyadisease:comparison with dynamic susceptibilitycontrast MRI[J]. Neuroradiology,2013,55(5):639-647.[13] BIVARD A,KRISHNAMURTHY V,STANWELLP,et al. Arterial spin labeling versus bolus-trackingperfusion in hyperacute stroke[J]. Stroke,2014,45(1):127-133.[14] FAN A P,GUO J,KHALIGHI M M,et al. Longdelayarterial spin labeling provides more accuratecerebral blood flow measurements in moyamoyapatients:a simultaneous positron emissiontomography/MRI study[J]. Stroke,2017,48(9):2441-2449.[15] CAMPBELL A M,BEAULIEU C. Pulsed arterialspin labeling parameter optimization for an elderlypopulation[J]. J Magn Reson Imaging,2006,23(3):398-403.[16] LEE S,YUN T J,YOO R E,et al. Monitoringcerebral perfusion changes after revascularizationin patients with moyamoya disease by using arterialspin-labeling MR imaging[J]. Radiology,2018,288(2):565-572.